AI assistant
UNIFI INC — Director's Dealing 2017
Sep 1, 2017
34323_dirs_2017-09-01_07a7faae-2bf8-4770-be25-c509e0acda94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNIFI INC (UFI)
CIK: 0000100726
Period of Report: 2017-08-30
Reporting Person: LANGONE KENNETH G (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-30 | Common Stock | M | 6666 | $8.16 | Acquired | 1109963 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-08-30 | Stock Option (Right to Buy) | $8.16 | M | 6666 | Disposed | 2017-10-24 | Common Stock (6666) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 30000 | Indirect |
| Common Stock | 130000 | Indirect |
Footnotes
F1: Represents shares delivered upon the exercise of a stock option.
F2: The reporting person disclaims beneficial ownership of these securities, and this Form 4 shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3: The reporting person is the principal equity holder and President and CEO of Invemed Associates LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the reporting person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by such entity. The reporting person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or are not actually distributed to him.
F4: The option was previously reported as covering 20,000 shares of the issuer's common stock at an exercise price of $2.72 per share, but was adjusted to reflect the 1-for-3 reverse stock split that occurred on November 3, 2010.
F5: The option became exercisable in two equal installments on (i) December 16, 2013, the date that the closing price of the issuer's common stock on the New York Stock Exchange was at least $24.00 per share for 30 consecutive trading days, and (ii) March 4, 2015, the date that the closing price of the issuer's common stock on the New York Stock Exchange was at least $30.00 per share for 30 consecutive trading days.